FDA’s Sickle Cell Patient-Focused Drug Development Meeting: This is a reminder about the upcoming public meeting on sickle cell disease, as part of FDA’s Patient-Focused Drug Development initiative. The purpose of the meeting is to hear patient perspectives on the health effects of sickle cell disease and on treating sickle cell disease. This meeting will allow FDA to hear patients views on the impact of sickle cell disease on their daily lives and the types of treatment benefit that matter most to patients. FDA is interested in getting a better understanding of your views on the disease, including the symptoms that matter most, limitations to current treatment and patients thoughts on new treatment approaches for sickle cell disease. This meeting is free and open to the public. Please help us reach patients and caregivers! This is an important opportunity to bring the sickle cell disease patient’s voice to FDA; therefore, patient participation is essential. Please help us make this meeting a success by reaching out and encouraging patients, parents and other caregivers to attend Meeting information: Date: February 7, 2014 Time: 10:00 am – 4:00 pm Location: FDA White Oak campus Building 31 (Great Room) 10903 New Hampshire Avenue, Silver Spring, MD 20993 Attendees can register through January 27, 2014 here: patientfocusedsicklecell.eventbrite/. Contribute to the meeting dialogue! The meeting format maximizes patient participation. For each discussion topic, a small panel of patients or caretakers will prove brief comments to start the dialogue. The panel comments will be followed by a facilitated discussion with others in the audience. Patients or caregivers who would like to be considered for an opening panel can indicate that as part of registration. They will be asked to send a short summary of their responses to the discussion questions (posted on our registration site) to [email protected]. Live Webcast: A live webcast will be available for those unable to attend in person. Web participants will be able to submit comments as part of the discussion through the webcast. Please register for the webcast at patientfocusedsicklecell.eventbrite/. Send in Comments: Patients and anyone else who is interested can also share their perspectives by submitting a comment to FDA. Click here to send comments: regulations.gov/#!documentDetail;D=FDA-2013-N-1328-0001.
Posted on: Wed, 29 Jan 2014 00:45:16 +0000
Trending Topics
Recently Viewed Topics
© 2015